CD274 and cancer: Studies have shown that endogenous antitumor agents, such as interferon –γ, could induce a high expression of PD-L1 in certain types of cancer to reduce the chemotherapeutic effect; therefore, blocking the PD-1/PD-L1 pathway should increase the effect of chemotherapy [7].